25 XP   0   0   10

Simcere Pharmaceutical Group Ltd
Buy, Hold or Sell?

Let's analyse Simcere together

PenkeI guess you are interested in Simcere Pharmaceutical Group Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Simcere Pharmaceutical Group Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Simcere Pharmaceutical Group Ltd

I send you an email if I find something interesting about Simcere Pharmaceutical Group Ltd.

Quick analysis of Simcere (30 sec.)










What can you expect buying and holding a share of Simcere? (30 sec.)

How much money do you get?

How much money do you get?
HK$0.02
When do you have the money?
1 year
How often do you get paid?
38.5%

What is your share worth?

Current worth
HK$3.67
Expected worth in 1 year
HK$6.00
How sure are you?
69.2%

+ What do you gain per year?

Total Gains per Share
HK$2.50
Return On Investment
43.8%

For what price can you sell your share?

Current Price per Share
HK$5.70
Expected price per share
HK$5.03 - HK$5.83
How sure are you?
50%

1. Valuation of Simcere (5 min.)




Live pricePrice per Share (EOD)

HK$5.70

2. Growth of Simcere (5 min.)




Is Simcere growing?

Current yearPrevious yearGrowGrow %
How rich?$1.2b$850.6m$266.3m23.8%

How much money is Simcere making?

Current yearPrevious yearGrowGrow %
Making money$201.1m$49.9m$151.2m75.2%
Net Profit Margin45.7%8.8%--

How much money comes from the company's main activities?

3. Financial Health of Simcere (5 min.)




What can you expect buying and holding a share of Simcere? (5 min.)

Welcome investor! Simcere's management wants to use your money to grow the business. In return you get a share of Simcere.

What can you expect buying and holding a share of Simcere?

First you should know what it really means to hold a share of Simcere. And how you can make/lose money.

Speculation

The Price per Share of Simcere is HK$5.7. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Simcere.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Simcere, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is HK$3.67. Based on the TTM, the Book Value Change Per Share is HK$0.58 per quarter. Based on the YOY, the Book Value Change Per Share is HK$0.04 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is HK$0.04 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Simcere.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 HK$% of Price per ShareHK$% of Price per ShareHK$% of Price per ShareHK$% of Price per ShareHK$% of Price per Share
Usd Eps0.111.9%0.081.3%0.010.2%0.020.4%0.020.4%
Usd Book Value Change Per Share0.101.7%0.071.3%0.010.1%0.040.6%0.040.6%
Usd Dividend Per Share0.000.0%0.010.1%0.010.1%0.000.1%0.000.1%
Usd Total Gains Per Share0.101.7%0.081.4%0.010.2%0.040.7%0.040.7%
Usd Price Per Share0.99-1.24-1.12-0.84-0.84-
Price to Earnings Ratio2.27-5.58-104.56-38.88-38.88-
Price-to-Total Gains Ratio10.00-17.32-15.93-32.21-32.21-
Price to Book Ratio2.12-3.07-3.44-2.59-2.59-
Price-to-Total Gains Ratio10.00-17.32-15.93-32.21-32.21-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.7296
Number of shares1370
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.010.00
Usd Book Value Change Per Share0.070.04
Usd Total Gains Per Share0.080.04
Gains per Quarter (1370 shares)109.3954.88
Gains per Year (1370 shares)437.54219.50
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
12841042822198210
25681986643396430
3831229130465593650
41111639174287791870
5139204921801099891090
61672458261813011871310
71952868305615213851530
82233278349417415821750
92503687393219517801970
102784097437021719782190

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share2.00.00.0100.0%10.00.00.0100.0%13.00.00.0100.0%13.00.00.0100.0%13.00.00.0100.0%
Book Value Change Per Share2.00.00.0100.0%5.01.04.050.0%7.01.05.053.8%7.01.05.053.8%7.01.05.053.8%
Dividend per Share1.00.01.050.0%5.00.05.050.0%5.00.08.038.5%5.00.08.038.5%5.00.08.038.5%
Total Gains per Share2.00.00.0100.0%7.01.02.070.0%9.01.03.069.2%9.01.03.069.2%9.01.03.069.2%

Fundamentals of Simcere

About Simcere Pharmaceutical Group Ltd

Simcere Pharmaceutical Group Limited engages in the research, development, manufacture, and sale of pharmaceutical products for distributors and pharmacy chains and other pharmaceutical manufacturers in China. The company focusses on various therapeutic areas, including oncology, central nervous system, autoimmune, anti-infection, cardiovascular, and others. Its principal products include Sanbexin, an edaravone and dexborneol concentrated solution for injection; Endostar, a recombinant human endostatin injection; ENWEIDA, an envafolimab injection; COSELA, a trilaciclib hydrochloride for injection; Iremod, an iguratimod tablet; and XIANNUOXIN, a simnotrelvir tablets/ritonavir tablets. The company also offers promotion services for pharmaceutical products. It has a strategic regional licensing partnership with Vivoryon Therapeutics N.V. to develop and commercialize SIM0801 and other drugs in the Greater China region. In addition, the company engages in the manufacture of pharmaceutical ingredients; and property management business. Simcere Pharmaceutical Group Limited was founded in 1995 and is headquartered in Nanjing, China.

Fundamental data was last updated by Penke on 2024-04-16 04:55:04.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is efficient in making profit.
Using its investors money, the company is efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is very efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is fair priced.
Based on the earnings, the company is cheap.

1.1. Profitability of Simcere Pharmaceutical Group Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Simcere earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Simcere to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of 67.3% means that $0.67 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Simcere Pharmaceutical Group Ltd:

  • The MRQ is 67.3%. The company is making a huge profit. +2
  • The TTM is 45.7%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ67.3%TTM45.7%+21.7%
TTM45.7%YOY8.8%+36.8%
TTM45.7%5Y15.2%+30.4%
5Y15.2%10Y15.2%0.0%
1.1.2. Return on Assets

Shows how efficient Simcere is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Simcere to the Drug Manufacturers - Specialty & Generic industry mean.
  • 16.6% Return on Assets means that Simcere generated $0.17 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Simcere Pharmaceutical Group Ltd:

  • The MRQ is 16.6%. Using its assets, the company is efficient in making profit. +1
  • The TTM is 12.0%. Using its assets, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ16.6%TTM12.0%+4.6%
TTM12.0%YOY3.6%+8.5%
TTM12.0%5Y5.1%+7.0%
5Y5.1%10Y5.1%0.0%
1.1.3. Return on Equity

Shows how efficient Simcere is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Simcere to the Drug Manufacturers - Specialty & Generic industry mean.
  • 23.3% Return on Equity means Simcere generated $0.23 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Simcere Pharmaceutical Group Ltd:

  • The MRQ is 23.3%. Using its investors money, the company is efficient in making profit. +1
  • The TTM is 17.3%. Using its investors money, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ23.3%TTM17.3%+6.0%
TTM17.3%YOY5.9%+11.4%
TTM17.3%5Y11.3%+6.0%
5Y11.3%10Y11.3%0.0%

1.2. Operating Efficiency of Simcere Pharmaceutical Group Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Simcere is operating .

  • Measures how much profit Simcere makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Simcere to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Simcere Pharmaceutical Group Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY2.5%-2.5%
TTM-5Y1.7%-1.7%
5Y1.7%10Y1.7%0.0%
1.2.2. Operating Ratio

Measures how efficient Simcere is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 0.24 means that the operating costs are $0.24 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Simcere Pharmaceutical Group Ltd:

  • The MRQ is 0.242. The company is very efficient in keeping operating costs low. +2
  • The TTM is 0.227. The company is very efficient in keeping operating costs low. +2
Trends
Current periodCompared to+/- 
MRQ0.242TTM0.227+0.015
TTM0.227YOY0.106+0.121
TTM0.2275Y0.128+0.098
5Y0.12810Y0.1280.000

1.3. Liquidity of Simcere Pharmaceutical Group Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Simcere is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 2.35 means the company has $2.35 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Simcere Pharmaceutical Group Ltd:

  • The MRQ is 2.351. The company is able to pay all its short-term debts. +1
  • The TTM is 2.096. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ2.351TTM2.096+0.255
TTM2.096YOY1.703+0.392
TTM2.0965Y1.562+0.534
5Y1.56210Y1.5620.000
1.3.2. Quick Ratio

Measures if Simcere is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Simcere to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 1.94 means the company can pay off $1.94 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Simcere Pharmaceutical Group Ltd:

  • The MRQ is 1.938. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 1.975. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ1.938TTM1.975-0.037
TTM1.975YOY1.347+0.628
TTM1.9755Y1.173+0.802
5Y1.17310Y1.1730.000

1.4. Solvency of Simcere Pharmaceutical Group Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Simcere assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Simcere to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.29 means that Simcere assets are financed with 28.7% credit (debt) and the remaining percentage (100% - 28.7%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Simcere Pharmaceutical Group Ltd:

  • The MRQ is 0.287. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.313. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.287TTM0.313-0.026
TTM0.313YOY0.387-0.075
TTM0.3135Y0.517-0.205
5Y0.51710Y0.5170.000
1.4.2. Debt to Equity Ratio

Measures if Simcere is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Simcere to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 40.2% means that company has $0.40 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Simcere Pharmaceutical Group Ltd:

  • The MRQ is 0.402. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.457. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.402TTM0.457-0.056
TTM0.457YOY0.636-0.178
TTM0.4575Y1.538-1.081
5Y1.53810Y1.5380.000

2. Market Valuation of Simcere Pharmaceutical Group Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Simcere generates.

  • Above 15 is considered overpriced but always compare Simcere to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of 2.27 means the investor is paying $2.27 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Simcere Pharmaceutical Group Ltd:

  • The EOD is 1.669. Based on the earnings, the company is cheap. +2
  • The MRQ is 2.272. Based on the earnings, the company is cheap. +2
  • The TTM is 5.583. Based on the earnings, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD1.669MRQ2.272-0.603
MRQ2.272TTM5.583-3.311
TTM5.583YOY104.559-98.977
TTM5.5835Y38.879-33.296
5Y38.87910Y38.8790.000
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Simcere Pharmaceutical Group Ltd:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y-0.000
5Y-10Y-0.000
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Simcere is to cheap or to expensive compared to its book value.

Let's take a look of the Price to Book Ratio trends of Simcere Pharmaceutical Group Ltd:

  • The EOD is 1.555. Based on the equity, the company is underpriced. +1
  • The MRQ is 2.117. Based on the equity, the company is underpriced. +1
  • The TTM is 3.069. Based on the equity, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD1.555MRQ2.117-0.562
MRQ2.117TTM3.069-0.952
TTM3.069YOY3.444-0.375
TTM3.0695Y2.591+0.478
5Y2.59110Y2.5910.000
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Simcere Pharmaceutical Group Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.7760.584+33%0.041+1784%0.282+175%0.282+175%
Book Value Per Share--3.6663.278+12%2.528+45%2.011+82%2.011+82%
Current Ratio--2.3512.096+12%1.703+38%1.562+51%1.562+51%
Debt To Asset Ratio--0.2870.313-8%0.387-26%0.517-45%0.517-45%
Debt To Equity Ratio--0.4020.457-12%0.636-37%1.538-74%1.538-74%
Dividend Per Share---0.040-100%0.040-100%0.031-100%0.031-100%
Eps--0.8540.590+45%0.097+783%0.165+418%0.165+418%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Market Cap14756787456.000-40%20672994011.20025793285167.800-20%22997497190.255-10%17295057345.948+20%17295057345.948+20%
Net Profit Margin--0.6730.457+47%0.088+662%0.152+342%0.152+342%
Operating Margin----0%0.025-100%0.017-100%0.017-100%
Operating Ratio--0.2420.227+7%0.106+129%0.128+89%0.128+89%
Pb Ratio1.555-36%2.1173.069-31%3.444-39%2.591-18%2.591-18%
Pe Ratio1.669-36%2.2725.583-59%104.559-98%38.879-94%38.879-94%
Price Per Share5.700-36%7.7609.690-20%8.748-11%6.578+18%6.578+18%
Price To Free Cash Flow Ratio----0%-0%-0%-0%
Price To Total Gains Ratio7.345-36%9.99917.322-42%15.934-37%32.208-69%32.208-69%
Quick Ratio--1.9381.975-2%1.347+44%1.173+65%1.173+65%
Return On Assets--0.1660.120+38%0.036+363%0.051+227%0.051+227%
Return On Equity--0.2330.173+35%0.059+296%0.113+106%0.113+106%
Total Gains Per Share--0.7760.624+24%0.081+852%0.313+148%0.313+148%
Usd Book Value--1250014543.0531117016045.331+12%850662095.114+47%676964961.985+85%676964961.985+85%
Usd Book Value Change Per Share--0.0990.075+33%0.005+1784%0.036+175%0.036+175%
Usd Book Value Per Share--0.4690.420+12%0.324+45%0.257+82%0.257+82%
Usd Dividend Per Share---0.005-100%0.005-100%0.004-100%0.004-100%
Usd Eps--0.1090.076+45%0.012+783%0.021+418%0.021+418%
Usd Free Cash Flow----0%-0%-0%-0%
Usd Market Cap1888868794.368-40%2646143233.4343301540501.478-20%2943679640.353-10%2213767340.281+20%2213767340.281+20%
Usd Price Per Share0.730-36%0.9931.240-20%1.120-11%0.842+18%0.842+18%
Usd Profit--291154944.000201192448.000+45%49902820.707+483%72079234.864+304%72079234.864+304%
Usd Revenue--432554112.000447921600.000-3%178539712.000+142%233894508.308+85%233894508.308+85%
Usd Total Gains Per Share--0.0990.080+24%0.010+852%0.040+148%0.040+148%
 EOD+3 -4MRQTTM+19 -9YOY+21 -85Y+23 -610Y+23 -6

3.2. Fundamental Score

Let's check the fundamental score of Simcere Pharmaceutical Group Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-151.669
Price to Book Ratio (EOD)Between0-11.555
Net Profit Margin (MRQ)Greater than00.673
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than11.938
Current Ratio (MRQ)Greater than12.351
Debt to Asset Ratio (MRQ)Less than10.287
Debt to Equity Ratio (MRQ)Less than10.402
Return on Equity (MRQ)Greater than0.150.233
Return on Assets (MRQ)Greater than0.050.166
Total8/10 (80.0%)

3.3. Technical Score

Let's check the technical score of Simcere Pharmaceutical Group Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5070.695
Ma 20Greater thanMa 505.283
Ma 50Greater thanMa 1005.355
Ma 100Greater thanMa 2005.732
OpenGreater thanClose5.400
Total1/5 (20.0%)



Latest Balance Sheet

Balance Sheet of 2023-06-30. Currency in CNY. All numbers in thousands.

Summary
Total Assets12,689,633
Total Liabilities3,636,385
Total Stockholder Equity9,053,248
 As reported
Total Liabilities 3,636,385
Total Stockholder Equity+ 9,053,248
Total Assets = 12,689,633

Assets

Total Assets12,689,633
Total Current Assets5,889,508
Long-term Assets6,800,125
Total Current Assets
Cash And Cash Equivalents 2,446,295
Short-term Investments 10,943
Net Receivables 2,387,761
Inventory 673,442
Other Current Assets 157,777
Total Current Assets  (as reported)5,889,508
Total Current Assets  (calculated)5,676,218
+/- 213,290
Long-term Assets
Property Plant Equipment 2,184,614
Goodwill 142,474
Intangible Assets 544,224
Other Assets 416,942
Long-term Assets  (as reported)6,800,125
Long-term Assets  (calculated)3,288,254
+/- 3,511,871

Liabilities & Shareholders' Equity

Total Current Liabilities2,505,270
Long-term Liabilities1,131,115
Total Stockholder Equity9,053,248
Total Current Liabilities
Short-term Debt 459,553
Short Long Term Debt 459,553
Accounts payable 457,191
Total Current Liabilities  (as reported)2,505,270
Total Current Liabilities  (calculated)1,376,297
+/- 1,128,973
Long-term Liabilities
Long term Debt Total 618,723
Long term Debt 450,000
Capital Lease Obligations 246,848
Long-term Liabilities  (as reported)1,131,115
Long-term Liabilities  (calculated)1,315,571
+/- 184,456
Total Stockholder Equity
Common Stock3,094,608
Retained Earnings 5,642,035
Other Stockholders Equity 316,605
Total Stockholder Equity (as reported)9,053,248
Total Stockholder Equity (calculated)9,053,248
+/-0
Other
Capital Stock3,094,608
Cash And Equivalents2,446,295
Cash and Short Term Investments 2,457,238
Common Stock Shares Outstanding 2,664,046
Liabilities and Stockholders Equity 12,689,633
Net Invested Capital 9,962,801
Net Working Capital 3,384,238
Property Plant and Equipment Gross 2,184,614



Balance Sheet

Currency in CNY. All numbers in thousands.

 Trend2023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-30
> Total Assets 
0
6,766,870
0
7,752,638
0
10,943,410
0
9,946,321
0
10,161,143
0
9,940,128
0
10,781,113
0
12,689,633
12,689,633010,781,11309,940,128010,161,14309,946,321010,943,41007,752,63806,766,8700
   > Total Current Assets 
2,897,641
2,897,641
3,605,949
3,605,949
6,466,832
6,466,832
5,136,195
5,136,195
4,979,549
4,979,549
5,444,316
5,444,316
0
5,453,784
0
5,889,508
5,889,50805,453,78405,444,3165,444,3164,979,5494,979,5495,136,1955,136,1956,466,8326,466,8323,605,9493,605,9492,897,6412,897,641
       Cash And Cash Equivalents 
0
354,804
0
595,916
0
3,270,241
0
1,284,596
0
973,139
0
1,865,035
0
1,657,600
0
2,446,295
2,446,29501,657,60001,865,0350973,13901,284,59603,270,2410595,9160354,8040
       Short-term Investments 
0
546,996
0
2,956
0
3,634
0
1,218,000
0
1,210,078
0
990,368
0
964,226
0
10,943
10,9430964,2260990,36801,210,07801,218,00003,63402,9560546,9960
       Net Receivables 
1,363,412
1,363,412
1,705,114
1,705,114
1,914,800
1,914,800
2,197,921
2,197,921
2,436,132
2,436,132
2,190,424
2,190,424
2,377,247
2,377,247
0
2,387,761
2,387,76102,377,2472,377,2472,190,4242,190,4242,436,1322,436,1322,197,9212,197,9211,914,8001,914,8001,705,1141,705,1141,363,4121,363,412
       Inventory 
300,389
300,389
346,977
346,977
311,126
311,126
356,596
356,596
290,964
290,964
377,078
377,078
369,162
369,162
0
673,442
673,4420369,162369,162377,078377,078290,964290,964356,596356,596311,126311,126346,977346,977300,389300,389
       Other Current Assets 
332,040
332,040
954,986
954,986
967,031
967,031
79,082
79,082
69,236
69,236
21,411
21,411
85,549
85,549
0
157,777
157,777085,54985,54921,41121,41169,23669,23679,08279,082967,031967,031954,986954,986332,040332,040
   > Long-term Assets 
0
3,869,229
0
4,146,689
0
4,476,578
0
4,810,126
0
5,181,594
0
4,495,812
0
5,327,329
0
6,800,125
6,800,12505,327,32904,495,81205,181,59404,810,12604,476,57804,146,68903,869,2290
       Property Plant Equipment 
1,869,740
1,869,740
2,038,514
2,038,514
2,127,879
2,127,879
1,988,214
1,988,214
1,931,212
1,931,212
2,036,170
2,036,170
0
2,171,910
0
2,184,614
2,184,61402,171,91002,036,1702,036,1701,931,2121,931,2121,988,2141,988,2142,127,8792,127,8792,038,5142,038,5141,869,7401,869,740
       Goodwill 
0
142,474
0
172,788
0
172,788
0
172,788
0
172,788
0
172,788
0
172,788
0
142,474
142,4740172,7880172,7880172,7880172,7880172,7880172,7880142,4740
       Intangible Assets 
0
33,768
0
86,316
0
77,108
0
68,150
0
59,691
0
176,801
0
379,896
0
544,224
544,2240379,8960176,801059,691068,150077,108086,316033,7680
> Total Liabilities 
0
5,286,406
0
5,932,321
0
5,607,686
0
4,305,001
0
3,724,146
0
3,811,713
0
3,654,352
0
3,636,385
3,636,38503,654,35203,811,71303,724,14604,305,00105,607,68605,932,32105,286,4060
   > Total Current Liabilities 
3,428,505
3,428,505
3,863,131
3,863,131
3,497,158
3,497,158
3,552,921
3,552,921
3,063,763
3,063,763
3,057,070
3,057,070
0
2,963,728
0
2,505,270
2,505,27002,963,72803,057,0703,057,0703,063,7633,063,7633,552,9213,552,9213,497,1583,497,1583,863,1313,863,1313,428,5053,428,505
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
1,292,935
0
1,292,067
0
459,553
459,55301,292,06701,292,93500000000000
       Short Long Term Debt 
0
1,643,978
0
2,279,197
0
1,792,940
0
1,961,526
0
1,530,085
0
1,292,935
0
1,292,067
0
459,553
459,55301,292,06701,292,93501,530,08501,961,52601,792,94002,279,19701,643,9780
       Accounts payable 
254,851
254,851
220,459
220,459
242,077
242,077
195,817
195,817
323,951
323,951
378,790
378,790
0
334,444
0
457,191
457,1910334,4440378,790378,790323,951323,951195,817195,817242,077242,077220,459220,459254,851254,851
       Other Current Liabilities 
385,836
385,836
245,312
245,312
268,671
268,671
531,421
531,421
169,755
169,755
560,620
560,620
0
0
0
0
0000560,620560,620169,755169,755531,421531,421268,671268,671245,312245,312385,836385,836
   > Long-term Liabilities 
0
1,857,901
0
2,030,691
0
2,110,528
0
721,064
0
634,623
0
730,746
0
674,562
0
1,131,115
1,131,1150674,5620730,7460634,6230721,06402,110,52802,030,69101,857,9010
       Long term Debt Total 
0
0
0
1,420,758
0
1,468,980
0
123,927
0
74,239
0
170,253
0
155,921
0
618,723
618,7230155,9210170,253074,2390123,92701,468,98001,420,758000
       Capital Lease Obligations Min Short Term Debt
0
157,807
0
257,505
0
231,528
0
161,665
0
105,797
0
-1,071,454
0
-1,077,390
0
-212,705
-212,7050-1,077,3900-1,071,4540105,7970161,6650231,5280257,5050157,8070
> Total Stockholder Equity
0
1,480,464
0
1,820,317
0
5,301,789
0
5,641,320
0
6,436,997
0
6,128,415
0
7,126,761
0
9,053,248
9,053,24807,126,76106,128,41506,436,99705,641,32005,301,78901,820,31701,480,4640
   Common Stock
210
210
210
210
3,002,871
3,002,871
3,002,871
3,002,871
3,002,871
3,002,871
3,002,871
3,002,871
0
3,081,131
0
3,094,608
3,094,60803,081,13103,002,8713,002,8713,002,8713,002,8713,002,8713,002,8713,002,8713,002,871210210210210
   Retained Earnings Total Equity0000000000000000
   Accumulated Other Comprehensive Income 0000000000000000
   Capital Surplus 0000000000000000
   Treasury Stock0000000000000000
   Other Stockholders Equity 
14,532
14,532
156,686
156,686
151,481
151,481
293,567
293,567
139,962
139,962
158,892
158,892
209,994
209,994
316,605
316,605
316,605316,605209,994209,994158,892158,892139,962139,962293,567293,567151,481151,481156,686156,68614,53214,532



Balance Sheet

Currency in CNY. All numbers in thousands.




Cash Flow

Currency in CNY. All numbers in thousands.




Income Statement

Currency in HKD. All numbers in thousands.


Latest Income Statement (annual, 2022-12-31)

Gross Profit (+$)
totalRevenue6,319,096
Cost of Revenue-1,322,246
Gross Profit4,996,8504,996,850
 
Operating Income (+$)
Gross Profit4,996,850
Operating Expense-5,742,565
Operating Income862,505-745,715
 
Operating Expense (+$)
Research Development1,728,269
Selling General Administrative2,832,600
Selling And Marketing Expenses-
Operating Expense5,742,5654,560,869
 
Net Interest Income (+$)
Interest Income25,649
Interest Expense-55,897
Other Finance Cost-55,707
Net Interest Income25,459
 
Pretax Income (+$)
Operating Income862,505
Net Interest Income25,459
Other Non-Operating Income Expenses-
Income Before Tax (EBT)888,154862,505
EBIT - interestExpense = -55,897
932,768
988,665
Interest Expense55,897
Earnings Before Interest and Taxes (EBIT)-944,051
Earnings Before Interest and Taxes (EBITDA)1,205,490
 
After tax Income (+$)
Income Before Tax888,154
Tax Provision--40,478
Net Income From Continuing Ops928,632928,632
Net Income932,768
Net Income Applicable To Common Shares932,768
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net--25,459
 

Technical Analysis of Simcere
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Simcere. The general trend of Simcere is BEARISH with 42.9% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Simcere's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-42.9%) Bearish trend (42.9%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Simcere Pharmaceutical Group Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 5.78 < 5.8 < 5.83.

The bearish price targets are: 5.08 > 5.03 > 5.03.

Tweet this
Simcere Pharmaceutical Group Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Simcere Pharmaceutical Group Ltd. The current mas is .

The long score for the Moving Averages is 4/14.
The longshort score for the Moving Averages is -6/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Simcere Pharmaceutical Group Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Simcere Pharmaceutical Group Ltd. The current macd is 0.02258761.

The long score for the Moving Average Convergence/Divergence (MACD) is 4/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 4/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Simcere price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Simcere. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Simcere price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Simcere Pharmaceutical Group Ltd Daily Moving Average Convergence/Divergence (MACD) ChartSimcere Pharmaceutical Group Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Simcere Pharmaceutical Group Ltd. The current adx is 18.51.

The long score for the Directional Movement Index (DMI) is 2/7.
The longshort score for the Directional Movement Index (DMI) is 2/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Simcere shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bullish trend could be forming. +1
Simcere Pharmaceutical Group Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Simcere Pharmaceutical Group Ltd. The current sar is 5.048216.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Simcere Pharmaceutical Group Ltd Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Simcere Pharmaceutical Group Ltd. The current rsi is 70.69. The current phase is Overbought in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is 0/(-13 +13).

  • Overbought in bear market: Short-term excessive buying, potential for relief decline. Consider shorting, be cautious of potential pullback. -1
  • Trending up: The RSI is trending up. +1
Simcere Pharmaceutical Group Ltd Daily Relative Strength Index (RSI) ChartSimcere Pharmaceutical Group Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Simcere Pharmaceutical Group Ltd. The current phase is Overbought in bear market.

The long score for the Stochastic Oscillator is 6/6.
The longshort score for the Stochastic Oscillator is 6/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH > 80: The STOCH %K is above 80 and overbought. +2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Simcere price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Simcere Pharmaceutical Group Ltd Daily Stochastic Oscillator ChartSimcere Pharmaceutical Group Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Simcere Pharmaceutical Group Ltd. The current cci is 301.48.

The long score for the Commodity Channel Index (CCI) is 1/1.
The longshort score for the Commodity Channel Index (CCI) is 1/(-1 +1).

  • CCI > 100: The CCI is above 100, it indicates that the price is significantly above its average, suggesting a potential overbought condition. +1
Simcere Pharmaceutical Group Ltd Daily Commodity Channel Index (CCI) ChartSimcere Pharmaceutical Group Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Simcere Pharmaceutical Group Ltd. The current cmo is 64.38.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Simcere Pharmaceutical Group Ltd Daily Chande Momentum Oscillator (CMO) ChartSimcere Pharmaceutical Group Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Simcere Pharmaceutical Group Ltd. The current willr is 0.

The long score for the Williams %R is 1/1.
The longshort score for the Williams %R is 1/(-1 +1).

  • WILLR > -20: The Williams %R is above -20. This indicates that the price is in overbought territory, suggesting a potential price correction or trend reversal to the downside. +1
Simcere Pharmaceutical Group Ltd Daily Williams %R ChartSimcere Pharmaceutical Group Ltd Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Simcere Pharmaceutical Group Ltd.

Simcere Pharmaceutical Group Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Simcere Pharmaceutical Group Ltd. The current atr is 0.15762582.

Simcere Pharmaceutical Group Ltd Daily Average True Range (ATR) ChartSimcere Pharmaceutical Group Ltd Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Simcere Pharmaceutical Group Ltd. The current obv is 80,973,017.

Simcere Pharmaceutical Group Ltd Daily On-Balance Volume (OBV) ChartSimcere Pharmaceutical Group Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Simcere Pharmaceutical Group Ltd. The current mfi is 59.89.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Simcere Pharmaceutical Group Ltd Daily Money Flow Index (MFI) ChartSimcere Pharmaceutical Group Ltd Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Simcere Pharmaceutical Group Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-05DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2023-12-06STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-07STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-11STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-12WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-12-13STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-14STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2023-12-18STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-21STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-12-22MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2023-12-28SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2023-12-29CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-02MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-04STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-10SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-12MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-16WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-17BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-19STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-22ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-24RSI LONG ENTRY SHORT CLOSE30 crossover to upside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-25MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-29WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-30CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-31BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-06RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-07SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-02-09MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-14STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-15SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-16SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-19CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-20CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-21DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-23STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-26CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-02-27STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-28STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-29STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-01STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-04CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-05DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-06WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-07MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-12MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-14SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-18STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-19STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-21STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-25STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-27STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-02SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-04-03WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-05DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-12MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-04-15CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-16WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-04-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-24MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-04-25DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-26STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-29SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-05-02WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).

6.3. Candlestick Patterns

Simcere Pharmaceutical Group Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Simcere Pharmaceutical Group Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5070.695
Ma 20Greater thanMa 505.283
Ma 50Greater thanMa 1005.355
Ma 100Greater thanMa 2005.732
OpenGreater thanClose5.400
Total1/5 (20.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Simcere with someone you think should read this too:
  • Are you bullish or bearish on Simcere? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Simcere? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Simcere Pharmaceutical Group Ltd

I send you an email if I find something interesting about Simcere Pharmaceutical Group Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Simcere Pharmaceutical Group Ltd.

Receive notifications about Simcere Pharmaceutical Group Ltd in your mailbox!